GlassScriptPhysician profile
Bradley A Eli
NPI 1205948270
$4,232.76
in general payments reported to CMS, 2019-2025
12 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $45.16 · 2021: $3,097 · 2022: $214 · 2023: $273 · 2024: $275 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prismatik Dentalcraft, INC. | $2,818.75 | 2021 | |
| Lundbeck LLC | $554.32 | 2021-2025 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $333.04 | 2019-2023 | Austedo Xr |
| Pfizer INC. | $179.89 | 2023-2025 | |
| Impel Pharmaceuticals LLC | $74.05 | 2024-2025 | Trudhesa |
| Impel Pharmaceuticals INC. | $69.46 | 2023 | Trudhesa |
| Inspire Medical Systems, INC. | $57.50 | 2024 | Inspire |
| Lilly USA, LLC | $56.20 | 2019-2025 | Emgality, Reyvow |
| Upsher-Smith Laboratories LLC | $23.74 | 2020 | |
| Abbvie INC. | $22.97 | 2024 | |
| Abbott Laboratories | $22.61 | 2022 | |
| Amgen INC. | $20.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Eli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.